Zhiliang Lu

2.2k total citations
38 papers, 1.6k citations indexed

About

Zhiliang Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhiliang Lu has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Zhiliang Lu's work include RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (15 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zhiliang Lu is often cited by papers focused on RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (15 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zhiliang Lu collaborates with scholars based in China, United States and United Kingdom. Zhiliang Lu's co-authors include Jie He, Jianbing Huang, Nan Sun, Yuanyuan Lei, Yuan Li, Shouguo Sun, Yun Che, Shuangshuang Mao, Zhaoli Chen and Chengming Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Zhiliang Lu

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiliang Lu China 23 1.1k 788 467 368 208 38 1.6k
Jianbing Huang China 22 1.1k 1.0× 715 0.9× 478 1.0× 345 0.9× 229 1.1× 42 1.6k
Cailu Song China 23 1.3k 1.2× 968 1.2× 483 1.0× 253 0.7× 155 0.7× 36 1.8k
Xinpei Deng China 22 1.1k 1.0× 666 0.8× 504 1.1× 474 1.3× 281 1.4× 51 1.7k
Yuhui Tang China 18 913 0.8× 554 0.7× 430 0.9× 471 1.3× 245 1.2× 28 1.4k
Zhihua Li China 23 919 0.8× 808 1.0× 738 1.6× 179 0.5× 254 1.2× 50 1.6k
Ce Li China 24 1.1k 1.0× 758 1.0× 624 1.3× 201 0.5× 310 1.5× 70 1.7k
Xiaojia Huang China 21 959 0.9× 845 1.1× 385 0.8× 177 0.5× 107 0.5× 40 1.4k
Giulia Bottai Italy 17 1.2k 1.1× 902 1.1× 588 1.3× 299 0.8× 230 1.1× 27 1.9k
Jeff C. Liu Canada 19 897 0.8× 434 0.6× 660 1.4× 197 0.5× 142 0.7× 25 1.4k

Countries citing papers authored by Zhiliang Lu

Since Specialization
Citations

This map shows the geographic impact of Zhiliang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiliang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiliang Lu more than expected).

Fields of papers citing papers by Zhiliang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiliang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiliang Lu. The network helps show where Zhiliang Lu may publish in the future.

Co-authorship network of co-authors of Zhiliang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiliang Lu. A scholar is included among the top collaborators of Zhiliang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiliang Lu. Zhiliang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chengming, et al.. (2024). A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy. Cancer Immunology Immunotherapy. 73(2). 37–37. 4 indexed citations
2.
Mao, Shuangshuang, Sufei Zheng, Zhiliang Lu, et al.. (2021). Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1. Translational Lung Cancer Research. 10(7). 3155–3172. 51 indexed citations
3.
Fan, Tao, Zhiliang Lu, Yu Liu, et al.. (2021). A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Frontiers in Immunology. 12. 665407–665407. 17 indexed citations
4.
Mao, Shuangshuang, Yuan Li, Zhiliang Lu, et al.. (2020). Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma. Cellular Oncology. 43(4). 681–694. 9 indexed citations
5.
Mao, Shuangshuang, Zhiliang Lu, Sufei Zheng, et al.. (2020). Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 193–193. 57 indexed citations
6.
Lei, Yuanyuan, Ruochuan Zang, Zhiliang Lu, et al.. (2020). ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells. Cell Death and Disease. 11(10). 853–853. 31 indexed citations
7.
Zheng, Sufei, Zhiliang Lu, Chengming Liu, et al.. (2019). The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis. Frontiers in Oncology. 9. 1340–1340. 5 indexed citations
8.
9.
Huang, Jianbing, Jiagen Li, Yuan Li, et al.. (2019). Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response. Cancer Letters. 459. 86–99. 37 indexed citations
10.
11.
Huang, Jianbing, Yuan Li, Zhiliang Lu, et al.. (2019). Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report. Cellular Oncology. 42(4). 571–578. 43 indexed citations
12.
Sun, Nan, Shouguo Sun, Zhiliang Lu, & Jie He. (2018). [Diagnostic value of protein markers in plasma exosomes of lung squamous cell carcinoma].. PubMed. 40(6). 418–421. 9 indexed citations
13.
14.
15.
Lu, Zhiliang, Zhaoli Chen, Yuan Li, et al.. (2018). TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling. Journal of Molecular Medicine. 96(3-4). 301–313. 37 indexed citations
16.
Wang, Jingnan, Zhirong Zhang, Yun Che, et al.. (2018). Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma. Cancer Chemotherapy and Pharmacology. 81(3). 469–481. 5 indexed citations
17.
Che, Yun, Jingnan Wang, Zuyang Yuan, et al.. (2017). The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation. Toxicology Letters. 280. 106–115. 12 indexed citations
18.
Lu, Zhiliang, Yuan Li, Jingnan Wang, et al.. (2017). Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway. Journal of Experimental & Clinical Cancer Research. 36(1). 54–54. 114 indexed citations
19.
Li, Yuan, Nan Sun, Zhiliang Lu, et al.. (2017). Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Cancer Letters. 393. 40–51. 158 indexed citations
20.
Li, Yuan, Xuejiao Shi, Wenhui Yang, et al.. (2016). Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing. Tumor Biology. 37(10). 13091–13100. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianbing Huang Breakdown of academic impact, for papers by Cailu Song Breakdown of academic impact, for papers by Xinpei Deng Breakdown of academic impact, for papers by Yuhui Tang Breakdown of academic impact, for papers by Zhihua Li Breakdown of academic impact, for papers by Ce Li Breakdown of academic impact, for papers by Xiaojia Huang Breakdown of academic impact, for papers by Giulia Bottai Breakdown of academic impact, for papers by Jeff C. Liu
Rankless by CCL
2026